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Available online 5 August 2016Complicated urinary tract infections, such as pyelonephritis, may lead to sepsis. Rapid diagnosis is needed to
identify the causative urinary pathogen and to verify the appropriate empirical antimicrobial therapy. We de-
scribe here a rapid identification method for urinary pathogens: urine is incubated on chocolate agar for 3 h at
35 °Cwith 5%CO2 and subjected toMALDI-TOFMS analysis byVITEKMS. Overall 207 screened clinical urine sam-
ples were tested in parallel with conventional urine culture. Themethod, called U-si-MALDI-TOF (urine short in-
cubation MALDI-TOF), showed correct identification for 86% of Gram-negative urinary tract pathogens
(Escherichia coli, Klebsiella pneumoniae, and other Enterobacteriaceae), when present at N105 cfu/ml in culture
(n = 107), compared with conventional culture method. However, Gram-positive bacteria (n = 28) were not
successfully identified by U-si-MALDI-TOF. This method is especially suitable for rapid identification of E. coli,
the most common cause of urinary tract infections and urosepsis. Turnaround time for identification using U-
si-MALDI-TOF compared with conventional urine culture was improved from 24 h to 4–6 h.





After respiratory tract infections, urinary tract infections (UTI) are
the second most common community-acquired infections that lead to
health care visits in the United States (Schappert & Rechtsteiner,
2011). Also hospital-acquired UTIs comprise as much as 36% of nosoco-
mial infections in theU.S. (Klevens et al., 2007), and about 9–31% of sep-
sis cases originate from urinary tract infections (Levy et al., 2012).
Urosepsis risk is increased in persons who are elderly, immunocompro-
mised, diabetic, pregnant, or carry structural urinary tract abnormali-
ties. Urosepsis may lead to severe sepsis and septic shock and its
mortality rate is around 5% (Foxman, 2014). Of patients with acute py-
elonephritis, only about 20–30% show positive blood cultures
(Sandberg et al., 2012), and thus the definitive diagnosis for the rest of
the pyelonephritis patients relies on the urine culture.
Most often UTI are caused by one bacterial species: in about 80% of
cases the causative agent is Escherichia coli. In typical laboratory UTI di-
agnostics, the pathogen is identified in 24 h, and the antibiotic suscepti-
bility testing (AST) results become available in 48 h. First, the patientsALDI-TOF MS, matrix-assisted
etry; SI, short incubation; UTI,
Haiko),
.fi (R. Hilla),are treated empirically, and the antibiotic will be changed according to
the susceptibility results when necessary.
Several rapid diagnostic methods for identification of pathogens in
urine samples have been introduced recently (Ferreira et al., 2010,
2011; Köhling et al., 2012; Burillo et al., 2014; DeMarco and Burnham,
2014; Kim et al., 2015; Veron et al., 2015; Íñigo et al., 2016). However,
all these methods include laborious pre-handling, e.g. centrifugation
or filtration steps, to get rid of other urine components, before MALDI-
TOF MS analysis. This is problematic for many clinical laboratories that
analyze hundreds of specimens daily. Minimal hands-on time is thus
appreciated and essential to implement a newmethod for daily routine.
A rapidmethod for identification of bacteria from positive blood cul-
ture bottles, called si-MALDI-TOF MS (short incubation matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry) has re-
cently been introduced (Bhatti et al., 2014; Kalanti et al., 2014;
Kohlmann et al., 2015; Zabbe et al., 2015). In this method a few drops
of blood from a positive blood culture bottle were incubated for a
short time (3–4 h) on a conventional chocolate agar and subjected to
MALDI-TOF MS even without visible colonies. By this method, Gram-
negative bacteria were correctly identified in 87% and Gram-positive
bacteria in 69% of the samples tested. E. coli was correctly identified in
91.5% of the samples (Kalanti et al., 2014).
Based on these results regarding blood cultures, we testedwhether a
3-h si-MALDI-TOFmethod could be useful for typically acquired clinical
urine samples to reduce the turnaround time for the pathogen
identification.
Table 1
Types of the clinical urine samples.
Sample type n (%)
Voided midstream 157 (76)
Intermittent catheter 16 (8)
Permcatch 8 (4)
Suprapubic catheter 4 (2)
Pyelostoma 2 (1)
Urine collection bag 2 (1)
Stoma 1 (0)
Not known 17 (8)
Total 207 (100)
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2.1. Clinical samples
The urine samples (Table 1), routinely submitted to the Department
of Bacteriology of Helsinki University Central Hospital HUSLAB for
urine culture, were analyzed. We selected samples that had shown
positive leukocyte and/or bacteria result (N10 × 103 leukocytes/ml
and N70 × 103 bacteria/ml) provided by Sysmex UF-1000i automated
flow cytometer (SysmexAmerica Inc., Lincolnshire, Illinois, USA) or pos-
itive leukocyte (at least 2 × 1010 leukocytes/ml) in the Urine Dipstick
Analysis done by The Department of Clinical Chemistry andHematology
at HUSLAB. The samples were collected into BD Vacutainer® Preserva-
tive tubes (Becton Dickinson and Company, Franklin Lakes, New Jersey,
USA) and stored overnight at 4 °C.2.2. Conventional urine culture
Urine was inoculated onto BD™ CHROMagar™ Orientation (Becton
Dickinson and Company) plate using a 1 μl calibrated loop (Berner
Pro, Helsinki, Finland) and incubated at 35 °C in ambient air for 18 h ac-
cording to our standard urine culture protocol. One or two significant
UTI pathogens were identified by routine MALDI-TOF MS (bioMérieux,
Marcy l'Etoile, France) from individual colonies. E. coliwas identified ei-
ther by the color reaction on CHROMagar or by routineMALDI-TOFMS.
When three or more organisms were observed, the result was
interpreted asmixed flora. The amount of bacteria (cfu/ml)was derived
by counting colonies on the CHROMagar plate, N10–100 colonies inocu-
lated with a 1 μl loop representing 104–105 cfu/ml in the urine sample,
and N100 colonies representing N105 cfu/ml.Table 2
Accuracy of U-si-MALDI-TOF for identification of Gram-negative bacteria.
Culture result cfu/ml n U-si-MALDI-TOF correct identificat
n (%)
Escherichia coli N 105 87a 75 (86)
Escherichia coli 104–5 7b 1 (14)
Klebsiella pneumoniae N 105 7c 7 (100)
Klebsiella oxytoca N 105 3c 2 (67)
Citrobacter sp. N105 3c 3 (100)
Enterobacter sp. N105 4c 3 (75)
Pseudomonas aeruginosa N 105 1c 1 (100)
Proteus mirabilis N 105 1c 1 (100)
Morganella morganii N 105 1c 0 (0)
a 86 identified by CHROMagar reaction and 6 by MALDI-TOF.
b 6 identified by CHROMagar reaction and 1 by MALDI-TOF.
c Identified by MALDI-TOF.
d Citrobacter sp. 1 × 97.5%.
e Proteus vulgaris/penneri.2.3. Sample preparation for U-si-MALDI-TOF and routine MALDI-TOF
analysis
The samples were mixed by inverting the tubes a few times, and
200 μl of urine was pipetted on chocolate agar plate as a spot. Two
spots per sample were performed. The plates were incubated at 35 °C
with 5% CO2 for 3 h. After incubation, a sample from the spot area
with visible or invisible growth was taken with a 1 μl loop to the
MALDI-TOF target plate. The spot was subjected to routine MALDI-TOF
MS with 1 μl of α-cyano-4-hydroxycinnamic acid (CHCA) matrix and
air-drying at room temperature. MALDI-TOF MS measurements were
performed on VITEKMSmass spectrometer (bioMérieux) and analyzed
against the IVD database by MYLA Software (bioMérieux). The VITEK
MS IVD database consists of ca. 750 clinically relevant species with an
average of N14 isolates/species and 36mass spectra/species. The results
appear as percentages, 99.9% being the highest value. The identification
was acceptedwhen ≥97.5% identificationwas detected in at least one of
the duplicate spots, and when the species identified was a potential
uropathogen. However, if the results were discordant in the duplicate
spots (two different species), or if the identification resulted in species
that does not grow on CHROMagar or on chocolate agar or was not a
uropathogen, the sample was regarded as negative.3. Results
Two hundred seven screening test positive urine samples were ana-
lyzed in parallel with U-si-MALDI-TOF and conventional culture. In con-
ventional urine culture, 16 samples were negative, 49 samples grew
mixed flora, and 142 samples showed significant growth (N105 or
104–5 cfu/ml) of one colony morphology. Compared to conventional
urine culture, the overall sensitivity of U-si-MALDI-TOF was 67% and
specificity 79% for the detection of uropathogens. Positive predictive
value of the test was 87% and negative predictive value 55%.
Of the 142 samples showing significant growth, E. coli N 105 cfu/ml
represented the majority (87/142), and U-si-MALDI-TOF successfully
identified 75 (86%) of them (Table 2). Of the rest of the samples with
E. coli N 105 cfu/ml, 11 (13%) were negative with U-si-MALDI-TOF, and
one gave a U-si-MALDI-TOF result of Citrobacter sp. instead of E. coli.
This E. coli was identified in conventional culture by the red color reac-
tion on CHROMagar, not by MALDI-TOF MS. Only one (14%) sample
with 104–5 cfu/ml of E. coli was correctly identified by U-si-MALDI-
TOF, and the rest consisting of six samples (86%) gave negative results.
Unspecific recognition with poor identification percentage or bacteria
of the normal microbiota of the urogenital tract (Lactobacillus sp.,




1 (1)d 11 (13)
0 (0) 6 (86)
0 (0) 0 (0)
1 (33)e 0 (0)
0 (0) 0 (0)
0 (0) 1 (25)
0 (0) 0 (0)
0 (0) 0 (0)
0 (0) 1 (100)
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interpreted as negative.
In 20 samples, a Gram-negative rod other than E. coli (N105 cfu/ml)
was identified by conventional culture. Of those, 17 (85%)were correct-
ly identified by U-si-MALDI-TOF. K. pneumoniaewas successfully identi-
fied in 7/7 (100%) samples. One Klebsiella oxytoca was incorrectly
identified as Proteus sp. by U-si-MALDI-TOF. Furthermore, one Entero-
bacter sp. and one Morganella morganii gave negative results by U-si-
MALDI-TOF.
U-si-MALDI-TOF did not perform as well in samples with Gram-pos-
itive bacteria (growth N105 or 104–5 cfu/ml). From 28 conventional cul-
tures that generated Gram-positive growth, 14 were identified as
Enterococcus faecalis by routine MALDI-TOF MS; only one of these was
correctly identified using U-si-MALDI-TOF assay. All other samples ana-
lyzed by U-si-MALDI-TOF gave a false negative result (Table 3).
The conventional culture resulted in mixed flora in 49/207 samples,
most of which represented voided midstream urine samples. Of the
mixed flora samples, 37 (67%), were regarded as negative in U-si-
MALDI-TOF assay. Of those, 27 samples gave no result, and 10 samples
showed unspecific recognition with “impossible” result, discordant re-
sult in duplicate spots and/or poor identification percentage, or species
that was not a uropathogen. E. coli was detected in six samples, and
other Gram-negative rods in six samples (Enterobacter aerogenes,
Morganella morganii, Proteus vulgaris/penneri, Serratia marcescens, and
two Klebsiella pneumoniae) by U-si-MALDI-TOF in both duplicate spots
in the mixed flora samples. All culture negative samples (16/207)
were negative also in U-si-MALDI-TOF analysis.
4. Discussion
Using U-si-MALDI-TOF we were able to correctly identify 86% (92/
107) of the Gram-negative urinary pathogens in samples with bacterial
load of N105 cfu/ml. Our results suggest that short incubation combined
withMALDI-TOFMSmight be useful for the identification of Gram-neg-
ative urinary pathogens, in particular E. coli, when urine bacterial count
is N105 cfu/ml. This is in line with previous findings regarding similar
methods (Ferreira et al., 2010, 2011; DeMarco and Burnham, 2014;
Veron et al., 2015). We propose that this method can be used in
attempting to diagnose patients with suspected pyelonephritis and
urosepsiswhen rapid diagnosis is invaluable and the amount of bacteria
in urine is usually high; however, further evaluation is needed for sam-
ples of patients with these diagnoses. Under certain clinical situations,
such as samples of the pyelostomy or paracentesis of the urinary blad-
der, a cfu/ml value less than 105 could be significant, and in these
cases, conventional urine culture would be recommended instead of
U-si-MALDI-TOF analysis.
The conventional urine culture, in which the bacteria are identified
on the basis of the color reaction on chromogenic agar or with MALDI-
TOFMS, requires an overnight incubation. The final result with antibiot-
ic susceptibility is usually available after 48 h. The use of various tests,
such as nitrite, leukocyte, and/or bacterial count and Gram staining
have been assessed for rapid identification of bacteria from urine sam-
ples (Ferreira et al., 2010; Burillo et al., 2014; Veron et al., 2015).Table 3
Accuracy of U-si-MALDI-TOF for identification of Gram-positive bacteria.
Culture result cfu/ml
(identified by MALDI-TOF MS)
n U-s
n (%
Staphylococcus aureus N 105 3 0 (0
Enterococcus faecalis 104–5/N105 14 1 (7
Staphylococcus epidermidis N 105 2 0 (0
Streptococcus agalactiae 104–5/N105 4 0 (0
Streptococcus viridans 104–5 1 0 (0
Lactobacillus sp. N105 4 0 (0However, the sensitivity, specificity, and hands-on time of these tests
varies. Using U-si-MALDI-TOF we were able to shorten the turnaround
time of the identification process of Gram-negative urinary pathogens
from 24 h to 4–6 h.
In complicated UTI it is critical to know the causative pathogen to be
able to change the empirical antibiotic treatment accordingly. This is
important when, e.g. P. aeruginosa or another AmpC-producing species,
such as Enterobacter cloacae, Citrobacter sp., or M. morganii, is involved.
Unfortunately we only had one P. aeruginosa sample in our study, any-
how it was correctly identified. Overall, the amount of Gram-negative
rods other than E. coli was rather small in our analysis, and this needs
further investigation.
The si-MALDI-TOF of positive blood cultures correctly identifies 87%
of Gram-negative bacteria and 69% of Gram-positive bacteria (Kalanti et
al., 2014). Notably, the bacterial amount in a positive blood culture bot-
tle is higher (106–109 cfu/ml) comparedwith the bacterial load in a typ-
ical urine sample (103–106 cfu/ml). This may be the reason why Gram-
positive bacteria failed to be identified using U-si-MALDI-TOF. Use of
collection tubes with preservative agents may alter the amount of
Gram-positive bacteria more than that of Gram-negative bacteria.
The use of MALDI-TOF MS for direct identification of urinary tract
pathogens has been evaluated by few studies, but typically these
methods require various sample preparation protocols, such as centrifu-
gation or filtration steps (Ferreira et al., 2010, 2011; Köhling et al., 2012;
Burillo et al., 2014; DeMarco and Burnham, 2014; Kim et al., 2015;
Veron et al., 2015; Íñigo et al., 2016). Our method is able to avoid labo-
rious pre-handling steps maybe because the components that disturb
theMS analysis are either absorbed into the solid medium or lysed dur-
ing the incubation. The advantages of thismethod are its rapidness, eas-
iness, and minimal hands-on time. The only significant cost is the
purchase of MALDI-TOF mass spectrometer, which is however already
routinely used in many clinical laboratories in the Western countries
nowadays.
U-si-MALDI-TOF would complement the diagnostics of urosepsis,
especially when combined with rapid AST. Rapid AST made directly
from the urine sample by disk diffusion would reduce the turnaround
time with several hours to b24 h, and this has actually been tested by
Enterobacteriaceae with good results (Sundqvist et al., 2015). Also
other methods, such as isothermal microcalorimetry (Braissant et al.,
2014) and 16S rRNA basedmethod (Mezger et al., 2015) have been suc-
cessfully applied for rapid AST from the urine samples. Combining rapid
identification with rapid AST could improve the treatment results of
urosepsis patients and even reduce the time and costs of hospital stays.
5. Conclusions
U-si-MALDI-TOF MS is a reliable rapid method for the identification
of the Gram-negative bacteria, the most common causative agents of
UTI and urosepsis. In the future, the method could be incorporated to
the diagnostic work-up of pyelonephritis and sepsis when rapid identi-
fication of urinary pathogens is needed. Combined with rapid AST, it
could significantly advance the diagnostics of UTI and reduce related
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